AccessPak for HIV PEP Expanded with Kaletra and Apraclonidine ophthalmic
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Apraclonidine ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: apraclonidine ophthalmic
Brand name: Iopidine
Synonyms: Apraclonidine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Apremilast
- AccessPak for HIV PEP Expanded with Kaletra-Aprepitant
- AccessPak for HIV PEP Expanded with Kaletra-Aprepitant Capsules
- AccessPak for HIV PEP Expanded with Kaletra-Aprepitant Injection
- AccessPak for HIV PEP Expanded with Kaletra-Aprepitant Intravenous
- AccessPak for HIV PEP Expanded with Kaletra-Aprepitant Oral Suspension
- Apraclonidine ophthalmic-AccessPak for HIV PEP Expanded with Viracept
- Apraclonidine ophthalmic-Accolate
- Apraclonidine ophthalmic-Accretropin
- Apraclonidine ophthalmic-Accucaine
- Apraclonidine ophthalmic-AccuHist Drops
- Apraclonidine ophthalmic-AccuHist PDX Drops